LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

Kodu・Aktsiate loetelu・Medpace Holdings Inc

Medpace Holdings Inc

Suletud

SektorTervishoid

306.35 0.19

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

301.79

Max

310.11

Põhinäitajad
By Trading Economics
Sissetulek	-2.4M 115M
Müük	22M 559M
P/E Sektori keskmine	23.357 56.602
Aktsiakasum	3.67
Kasumimarginaal	20.516
Töötajad	5,900
EBITDA	-4.9M 120M

Soovitused
By TipRanks
Soovitused	Neutraalne
12 kuu keskmine prognoos	+4.09% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	21. juuli 2025

Turustatistika
By TradingEconomics
Turukapital	-162M 8.8B
Eelmine avamishind	306.16
Eelmine sulgemishind	306.35

Uudiste sentiment

By Acuity

50%

372 / 382 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

300 / 302.88 Toetus ja vastupanu

Medpace Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

20. mai 2025, 20:54 UTC

Omandamised, ülevõtmised, äriostud

PNC to Buy Private-Equity Agent Aqueduct Capital

20. mai 2025, 20:50 UTC

Tulu

Palo Alto Networks Posts Higher 3Q Sales, Profit Slips

20. mai 2025, 23:48 UTC

Omandamised, ülevõtmised, äriostud

Kraft Heinz Evaluating Strategic Transactions, Berkshire Hathaway Steps Away From Board -- Update

20. mai 2025, 23:42 UTC

Market Talk

Nikkei May Trade Rangebound Amid Tariff Uncertainty -- Market Talk

20. mai 2025, 23:39 UTC

Market Talk

Gold Steady, Supported by Lingering U.S. Fiscal-Deficit Concerns -- Market Talk

20. mai 2025, 23:08 UTC

Market Talk

James Hardie's Repair & Remodel Outlook Surprises RBC -- Market Talk

20. mai 2025, 22:46 UTC

Omandamised, ülevõtmised, äriostud

Gold Road: Takeover Remains Subject to Independent Expert Findings; Shareholder, Court Approval

20. mai 2025, 22:45 UTC

Omandamised, ülevõtmised, äriostud

Gold Road: Notified Australia Government Has No Objections to Takeover by Gold Fields

20. mai 2025, 22:20 UTC

Peamised uudised

In Latest EV Pullback, Ford to Share Battery Plant With Nissan -- WSJ

20. mai 2025, 22:00 UTC

Tulu

ZTO Express (Cayman) 1Q Adj EPS 37c >ZTO

20. mai 2025, 22:00 UTC

Tulu

ZTO Express (Cayman) 1Q EPS 34c >ZTO

20. mai 2025, 22:00 UTC

Tulu

ZTO Express (Cayman) 1Q Rev $1.5B >ZTO

20. mai 2025, 21:44 UTC

Tulu

James Hardie Industries 4Q Adj EPS 36c >JHX

20. mai 2025, 21:44 UTC

Tulu

James Hardie Industries: Sees FY26 North America Net Sales Growth Up Low Single Digits >JHX

20. mai 2025, 21:44 UTC

Tulu

James Hardie Industries 4Q EPS 10c >JHX

20. mai 2025, 21:44 UTC

Tulu

James Hardie Industries 4Q Sales $972M >JHX

20. mai 2025, 20:52 UTC

Peamised uudised

Elon Musk to Cut Back Political Spending -- 3rd Update

20. mai 2025, 20:52 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20. mai 2025, 20:52 UTC

Market Talk

Mexican Stocks Near Record High As Trade Concerns Ease -- Market Talk

20. mai 2025, 20:30 UTC

Omandamised, ülevõtmised, äriostud

PNC Financial: Aqueduct Acquisition Expected to Close in Mid-Summer, Terms Won't be Disclosed >PNC

20. mai 2025, 20:28 UTC

Omandamised, ülevõtmised, äriostud

PNC Bank Agrees To Acquire Aqueduct Capital Group To Complement Harris Williams Capabilities >PNC

20. mai 2025, 20:23 UTC

Omandamised, ülevõtmised, äriostud

Tesla CEO Musk Says He Plans to Be at White House for a Couple Days Every Few Weeks

20. mai 2025, 20:22 UTC

Tulu

XP 1Q Adj EPS BRL2.29 >XP

20. mai 2025, 20:22 UTC

Tulu

XP 1Q Rev BRL4.345B >XP

20. mai 2025, 20:21 UTC

Omandamised, ülevõtmised, äriostud

Tesla CEO Musk: 'We're in the Big Bang of Intelligence Explosion'

20. mai 2025, 20:20 UTC

Peamised uudised

Fed's Bostic Signals Longer Delay in Cutting Interest Rates -- Barrons.com

20. mai 2025, 20:19 UTC

Omandamised, ülevõtmised, äriostud

Tesla CEO Musk Says He Doesn't Currently Have Plans to Merge Tesla, xAI

20. mai 2025, 20:11 UTC

Peamised uudised

Venezuela Frees U.S. Air Force Veteran in Overture to Trump -- Update

20. mai 2025, 20:09 UTC

Tulu

Palo Alto Networks 3Q Remaining Performance Obligation $13.5 B >PANW

20. mai 2025, 20:08 UTC

Tulu

Palo Alto Networks Sees FY25 Adj EPS $3.26-Adj EPS $3.28 >PANW

Võrdlus sarnastega

Hinnamuutus

Medpace Holdings Inc Prognoos

Hinnasiht

By TipRanks

4.09% tõus

12 kuu keskmine prognoos

Keskmine 318.5 USD 4.09%

Kõrge 355 USD

Madal 285 USD

Põhineb 7 Wall Streeti analüütiku instrumendi Medpace Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

7 ratings

Osta

Hoia

Müü

Põhineb 7 analüütiku instrumendi Medpace Holdings Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

300 / 302.88Toetus ja vastupanu

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

372 / 382 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.